Neby Bekele - Concepedia

Author

Neby Bekele

Also Known As

Neby Bekele

Publications

409

Citations

H-Index

Concepts

All Affiliations

Neby Bekele is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	148
2	Pathology	2	2	136
3	Gastroenterology	1	1	93
4	Pharmacology	1	1	12
5	Surgical Oncology	1	1	93

Neby Bekele

Publications

403

Citations

H-Index

Page 1

	Year	Citations
Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials Evguenia S. Svarovskaia, Hadas Dvory‐Sobol, Neil Parkin, Clinical Infectious Diseases	2014	213
Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System Wayne L. Hofstetter, Arlene M. Correa, Neby Bekele, The Annals of Thoracic Surgery Nodal StatusSurgical OncologyEsophagusEsophageal CancerMedicine	2007	93
A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. Luo Wang, Marivonne Rodriguez, Edward S. Kim, International Journal of Oncology Neck CancerNovel C/t PolymorphismEpigenetic ChangeGeneticsHuman Polymorphism	2004	43
Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice Wenjuan Wu, Michael S. O’Reilly, Robert R. Langley, Molecular Cancer Therapeutics	2007	42
A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia Apostolia M. Tsimberidou, Michael J. Keating, Elias Jabbour, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyOncologyOxaliplatin TherapyMixed-phenotype Acute LeukemiaPharmacology	2014	12

Page 1